Mariela del Pino

First year of nirsevimab use in Argentina (2025): Reportfrom a private vaccination center

Vanesa Castellano, Mariela del Pino, Sofía Diana Menéndez, Fernando Fernández et autres

Introduction. Since March 2025, nirsevimab, a monoclonal antibody for the prevention of respiratory syncytial virus infection (RSV), has been available in Argentina. The objective of this study was to describe the use of nirsevimab at a private vaccination center in the Buenos …

ar (code pays fourni par la source)

Perception of vaccine myths in daily clinical practice:A survey of healthcare professionals

Vanesa Castellano, Mariela del Pino, Sofía Diana Menéndez, Pablo Bonvehí et autres

Introduction. Misinformation is a barrier to immunization. The objective was to describe and categorize vaccine-related myths reported by healthcare professionals (HCPs). Population and methods. A descriptive, retrospective study was conducted using a survey administered during registration for a vaccine symposium, in which …

ar (code pays fourni par la source)

Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines

Ángela Gentile, Vanesa Castellano, Anabella Pacchiotti, Mariela del Pino et autres

Introduction: In Argentina, a pentavalent whole-cell pertussis vaccine (wP) is used in the National Immunization Program, however hexavalent acellular pertussis (aP) vaccines are available in the private market. Objective: To describe parent or guardianś perceptions on reactogenicity, daily routine and satisfaction after …

ar, fr, mx (code pays fourni par la source)

Vaccination status in patients at risk for invasive disease with encapsulated bacteria at a children’s hospital in the City of Buenos Aires

Mariela del Pino, Vanesa Castellano, Anabella Pacchiotti, Patricia Lamy et autres

Introduction. The Ministry of Health has established specific vaccines for people at high risk for invasive infections with encapsulated bacteria (EB). There is currently no information about compliance with the vaccination schedule. Our objective was to assess EB vaccination status in subjects …

ar (code pays fourni par la source)

Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: Prospective cohort study from a hospital in Argentina

Ángela Gentile, V.E. Castellano, Anabella Pacchiotti, Natacha Weinberger et autres

Background: In December 2020, Sputnik V was incorporated to the National COVID-19 Immunization Plan in Argentina. Studies had shown 98% of antibody response rate. To date, data on immunogenicity and antibody persistence in Argentina are scarce.The objective was to assess humoral immune …

ar (code pays fourni par la source)

SARS-CoV-2 Antibody Response Following SPUTNIK V Vaccination in Healthcare Workers From a Hospital in Argentina: Preliminary Results

Ángela Gentile, Vanesa Castellano, Natacha Weinberger, Anabella Pacchiotti et autres

Tunisie, ar (code pays fourni par la source)

Esterilización femenina con pellets de quinacrina endouterinos

Sergio Guzmán C., Mariela del Pino, René Guzmán S.